{"entities": {"mentions": [{"start": 0, "end": 11, "username": "WhiteHouse", "id": "1323730225067339784"}], "urls": [{"start": 150, "end": 173, "url": "https://t.co/meOFm8hGNK", "expanded_url": "https://www.benzinga.com/node/15717785", "display_url": "benzinga.com/node/15717785"}], "annotations": [{"start": 89, "end": 91, "probability": 0.5179, "type": "Organization", "normalized_text": "FDA"}]}, "referenced_tweets": [{"type": "replied_to", "id": "1266459851070361601"}], "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "88", "name": "Political Body", "description": "A section of a government, like The Supreme Court"}, "entity": {"id": "871795678447456256", "name": "The White House", "description": "Conversation from and about the White House, both as a destination and as political voice"}}], "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "in_reply_to_user_id": "822215673812119553", "lang": "en", "conversation_id": "1266459851070361601", "created_at": "2020-05-29T20:26:46.000Z", "text": "@WhiteHouse BREAKING NEWS. 05/26/20\nDiffusion Pharmaceuticals(DFFN) Receives Accelerated FDA Response to Proposed TSC COVID-19 Clinical Trial Program\nhttps://t.co/meOFm8hGNK", "reply_settings": "everyone", "author_id": "3310124155", "source": "Twitter Web App", "possibly_sensitive": false, "id": "1266466032044183560"}